知镜 Cognispect · 医学文献与研究工作台

Paragangliomas and Pheochromocytomas: Integrating Developmental Biology With Translational Technologies. A Narrative Review.

de Bresser CJM, de Krijger RR.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026-09-03 · PMID 42692260

文献摘要

Pheochromocytomas and paragangliomas (PGLs) are rare neural crest-derived neuroendocrine neoplasms with highly variable clinical behavior and limited therapeutic options in metastatic disease. From a pathologic perspective, diagnosis and risk assessment have traditionally relied on histomorphology and immunohistochemistry. However, conventional parameters remain insufficient to reliably predict biological behavior. Over the past decade, genomic and transcriptomic profiling have refined molecular classification, yet genotype-based stratification alone does not fully explain heterogeneity in tumor progression, immune composition, or treatment response. This review examines the evolution of experimental and analytical approaches to PGLs through a pathology-centered lens. We first discussed how advances in developmental biology and molecular classification have reshaped understanding of tumor heterogeneity beyond morphology. We then highlighted the growing recognition of the tumor microenvironment as a critical determinant of tumor behavior. In this context, spatially resolved protein profiling, including multiplex immunofluorescence, has emerged as an important extension of traditional immunohistochemistry, enabling simultaneous visualization of immune and tumor cell populations within preserved tissue architecture. These approaches provide functional insight that cannot be derived from bulk genomic analyses alone. Despite these advances, translation into therapeutic innovations has been hampered by the lack of physiologically relevant human model systems. Early 2-dimensional cell cultures and rodent models provided foundational mechanistic insights but failed to recapitulate human tumor architecture and microenvironmental interactions. The recent establishment of patient-derived PGL organoids represents a significant step forward, preserving chromaffin lineage features and enabling ex vivo pharmacologic interrogation. Taken together, the progression from histopathological assessment to spatial immune profiling and advanced 3-dimensional human modeling defines a conceptual framework in which functional therapeutic testing may become integrated into future pathology-driven translational research in PGLs.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。